Table 3.
Characteristic | Admissionsa within 30 days |
Admissionsa within 120 days |
||||
---|---|---|---|---|---|---|
SHR | 95% CI |
SHR | 95% CI |
|||
LCL | UCL | LCL | UCL | |||
All patients combined | 2.7 | 2.4 | 2.9 | 4.0 | 3.8 | 4.1 |
Age group (years) | ||||||
<50 | 2.4 | 1.1 | 4.5 | 3.2 | 2.4 | 4.2 |
50–59 | 2.6 | 2.1 | 3.2 | 4.4 | 4.1 | 4.8 |
60–69 | 2.4 | 2.1 | 2.7 | 4.0 | 3.8 | 4.3 |
70–79 | 3.1 | 2.6 | 3.6 | 3.7 | 3.5 | 4.0 |
≥80 | 2.9 | 1.7 | 4.5 | 3.4 | 2.8 | 4.2 |
SIMD fifth | ||||||
1 – Most deprived | 2.6 | 2.1 | 3.2 | 3.3 | 3.0 | 3.5 |
2 | 2.3 | 1.8 | 2.9 | 3.5 | 3.2 | 3.8 |
3 | 2.4 | 1.9 | 3.0 | 4.1 | 3.7 | 4.4 |
4 | 3.0 | 2.5 | 3.7 | 4.6 | 4.3 | 5.0 |
5 – Least deprived | 2.9 | 2.4 | 3.4 | 4.4 | 4.1 | 4.7 |
Prior co-morbidity (Charlson score) | ||||||
0 conditions | 2.4 | 2.1 | 2.7 | 3.2 | 3.1 | 3.4 |
1–2 conditions | 3.1 | 2.7 | 3.6 | 5.4 | 5.1 | 5.6 |
≥3 conditions | 0.0 | NA | NA | 5.1 | 1.7 | 12.0 |
Prior co-morbidity (bed days)b | ||||||
0 | 2.4 | 2.1 | 2.7 | 3.2 | 3.1 | 3.4 |
1–10 | 3.1 | 2.7 | 3.6 | 5.4 | 5.1 | 5.6 |
≥11 | 0.0 | NA | NA | 0.0 | NA | NA |
Diagnosed with prostate cancerc | ||||||
Yes | 2.4 | 2.1 | 2.8 | 5.1 | 4.9 | 5.3 |
No | 2.9 | 2.5 | 3.2 | 2.9 | 2.7 | 3.1 |
LCL, lower confidence limit; UCL, upper confidence limit; NA, not applicable.
SIMD, Scottish Index of Multiple Deprivation.
Continuous inpatient stays.
Number of inpatient bed days in the five years (excluding the most recent six months) before prostate biopsy.
Within 120 days, before or after prostate biopsy date.